Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms

Carfì, 2020, Persistent symptoms in patients after acute COVID-19, J. Am. Med. Assoc., 324, 603, 10.1001/jama.2020.12603 Munz, 2020, Acute transverse myelitis after COVID-19 pneumonia, J. Neurol., 267, 2196 Chow, 2020, Acute transverse myelitis in COVID-19 infection, BMJ Case Rep., 13, 10.1136/bcr-2020-236720 Maideniuc, 2020, Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient, J. Neurol., 9, 1 Toscano, 2020, Guillain–barré syndrome associated with SARS-CoV-2, N. Engl. J. Med., 382, 2574, 10.1056/NEJMc2009191 Zachariadis, 2020, Transverse myelitis related to COVID-19 infection, J. Neurol., 267, 3459 Masuccio, 2020, A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection, J. Neurol., 17, 1 Chakraborty, 2020, COVID-19-associated acute transverse myelitis: a rare entity, BMJ Case Rep., 13, 10.1136/bcr-2020-238668 Kaur, 2020, Transverse myelitis in a child with COVID-19, Pediatr. Neurol., 112, 5, 10.1016/j.pediatrneurol.2020.07.017 Puntmann, 2020, Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19), JAMA Cardiol., 5, 1265, 10.1001/jamacardio.2020.3557 Guo, 2020, Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19), JAMA Cardiol., 5, 811, 10.1001/jamacardio.2020.1017 Lindner, 2020, Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases, JAMA Cardiol., 5, 1281, 10.1001/jamacardio.2020.3551 Driggin, 2020, Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic, J. Am. Coll. Cardiol., 75, 2352, 10.1016/j.jacc.2020.03.031 Nishiga, 2020, COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives, Nat. Rev. Cardiol., 17, 543, 10.1038/s41569-020-0413-9 Amaratunga, 2020, Bradycardia in patients with COVID-19: a calm before the storm?, Cureus, 12 Gupta, 2020, Bradyarrhythmias in patients with COVID-19: a case series, Indian Pacing Electrophysiol. J., 20, 211, 10.1016/j.ipej.2020.08.004 Ashok, 2020, Case report: high-grade atrioventricular block in suspected COVID-19 myocarditis, Eur. Heart J. Case Rep., 4, 1, 10.1093/ehjcr/ytaa248 Kir, 2020, Heart brake: an unusual cardiac manifestation of COVID-19, JACC Case Rep., 2, 1252, 10.1016/j.jaccas.2020.04.026 Hayek, 2020, In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study, BMJ, 371, m3513, 10.1136/bmj.m3513 Zhou, 2020, Clinical and autoimmune characteristics of severe and critical cases of COVID-19, Clin. Transl. Sci., 13, 1077, 10.1111/cts.12805 Ehrenfeld, 2020, Covid-19 and autoimmunity, Autoimmun. Rev., 19, 102597, 10.1016/j.autrev.2020.102597 Wang, 2020, vol. 12 Bastard, 2020, Autoantibodies against type I IFNs in patients with life-threatening COVID-19, Science, 370, 10.1126/science.abd4585 Novelli, 2020, The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - a systematic review of the literature, J. Autoimmun., 117 Lyons-Weiler, 2020, Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity, J. Transl. Autoimmun., 3 Kreye, 2020, A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model, Cell, 183, 1058, 10.1016/j.cell.2020.09.049 Khamsi, 2021, Rogue antibodies could be driving severe COVID-19, Nature, 590, 29, 10.1038/d41586-021-00149-1 Shoenfeld, 2020, Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy, Clin. Immunol., 214, 108384, 10.1016/j.clim.2020.108384 Scheibenbogen, 2018, Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME, PLoS One, 13, 10.1371/journal.pone.0193672 Wallukat, 2018, Functional autoantibodies in patients with different forms of dementia, PLoS One, 13 Düngen, 2020, β1-Adrenoreceptor autoantibodies in heart failure: physiology and therapeutic implications, Circ. Heart Fail., 13, 10.1161/CIRCHEARTFAILURE.119.006155 Harris, 2009, Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support, J. Biomed. Inf., 42, 377, 10.1016/j.jbi.2008.08.010 Davideit, 2019, Determination of agonistically acting autoantibodies to the adrenergic beta-1 receptor by cellular bioassay, Methods Mol. Biol., 1901, 95, 10.1007/978-1-4939-8949-2_8 Wenzel, 2017, Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy, Heliyon, 3, 10.1016/j.heliyon.2017.e00362 Wallukat, 2019, Analytics of functional autoantibodies in patients with chagas disease, Methods Mol. Biol., 1955, 247, 10.1007/978-1-4939-9148-8_19 Orjatsalo, 2020, Activating autoantibodies against G protein-coupled receptors in narcolepsy type 1, Sleep Med., 77, 82, 10.1016/j.sleep.2020.11.038 Wallukat, 2020, Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer, Auto Immun. Highlights, 11, 13, 10.1186/s13317-020-00136-y Hohberger, 2019, Autoantibodies activating the β2-adrenergic receptor characterize patients with primary and secondary glaucoma, Front. Immunol., 10, 2112, 10.3389/fimmu.2019.02112 Loebel, 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome, Brain Behav. Immun., 52, 32, 10.1016/j.bbi.2015.09.013 Kharraziha, 2020, Serum activity against G protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome, J. Am. Heart Assoc., 9 Kohr, 2011, Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome, Pain, 152, 2690, 10.1016/j.pain.2011.06.012 Fu, 2000, Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension, J. Hypertens., 18, 945, 10.1097/00004872-200018070-00017 Wallukat, 2003, Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia, Can. J. Physiol. Pharmacol., 81, 79, 10.1139/y02-160 Dragun, 2005, Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection, N. Engl. J. Med., 352, 558, 10.1056/NEJMoa035717 Lukitsch, 2012, Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies, Transplantation, 94, 8, 10.1097/TP.0b013e3182529bb7 Cremer, 2020, Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry, Clin. Res. Cardiol., 19, 1 Fouladseresht, 2020, Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19, Cytokine Growth Factor Rev., 58, 32, 10.1016/j.cytogfr.2020.10.002 Okruhlicova, 2007, Autoantibodies against G-protein-coupled receptors modulate heart mast cells, Cell. Mol. Immunol., 4, 127 Steckelings, 2020, Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists, Clin. Sci. (Lond.), 134, 2987, 10.1042/CS20200922 Haberland, 2013, Are agonistic autoantibodies against G-protein coupled receptors involved in the development of long-term side effects of tumor chemotherapy?, Case Rep. Oncol., 6, 104, 10.1159/000348425 Wallukat, 1991, Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization, Eur. Heart J., 12, 10.1093/eurheartj/12.suppl_D.178 Dandel, 2012, Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy, Eur. J. Heart Fail., 14, 1374, 10.1093/eurjhf/hfs123 Müller, 2000, Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy, Circulation, 101, 385, 10.1161/01.CIR.101.4.385 Jünemann, 2018, Agonistic autoantibodies to the β2-adrenergic receptor involved in the pathogenesis of open-angle glaucoma, Front. Immunol., 9, 145, 10.3389/fimmu.2018.00145